TestLine Clinical Diagnostics s.r.o.’s Post

Did you know? MASH, or metabolic dysfunction-associated steatohepatitis, is a serious, progressive, metabolic disease affecting the liver, which can be fatal if not managed properly. It is often described as a ‘silent disease’ due to the lack of specific symptoms in the early stages of the disease, which often contributes to a delay in diagnosis. 13 June is Global #FattyLiverDay 🌎 Learn more about living with the condition and the impact of a late diagnosis from Tania. Watch Tania’s story here: https://lnkd.in/dAw55qZV At Novo Nordisk, we are committed to continuing our research with the ambition of developing innovations that can help address the underlying cause of this disease. We hope to double diagnostic rates for people living with moderate to advanced MASH by 2027 💙

Today's observance of #RareDiseaseDay underscores the importance of patience and resilience for those affected by rare diseases. It's a journey filled with waiting—for the correct diagnosis, the right treatment, and breakthroughs that can offer new hope. At Johnson & Johnson, we’re advancing the science and chasing down breakthroughs in a variety of rare diseases such as PAH, AL amyloidosis, myasthenia gravis, rare inherited retinal diseases, rare maternal-fetal diseases, and rare blood disorders and cancers. Today, with our team, we spent time to reflect on our collective commitment to deepening our knowledge and empathy towards the rare disease community. This session was more than just an awareness opportunity—it was a moment for our team to come together, reflect on the challenges faced by those living with rare diseases, and reinforce our commitment to making a difference in their lives. #RareDiseaseDay #mycompany

There are more than 100 known autoimmune diseases, including rare autoantibody-driven conditions such as generalized myasthenia gravis, warm autoimmune hemolytic anemia, chronic inflammatory demyelinating polyneuropathy and idiopathic inflammatory myopathies. Patient advocates like Elisa are key partners to gaining insights that help increase understanding of these conditions. For this #AutoimmuneAwarenessMonth, our unwavering research, and ongoing efforts to increase treatment options for people living with rare autoantibody diseases remain at forefront, building on our commitment to deliver safer, more effective approaches: https://bit.ly/3IyA62d #JNJImmunology

Rare diseases, including some Autoimmune diseases, are incredibly challenging to diagnose and even harder to treat. Research and innovation are key to advancing diagnosis and treatment, and we’re helping raise awareness and generate change for those 300 million people living with rare diseases, as well as their families and caregivers. This #RareDiseaseDay we’re amplifying the voices of our team members around the world involved in delivering diagnostic solutions for autoimmune diseases, in a 4-part video series.   In the first video, Remy Wiertz, PhD and Johannes ALBERT share how raising awareness for rare diseases can improve understanding, drive research, and help those affected get the support they need. #RareDiseases #AutoimmuneDiseases #WeAreWerfen #SpecializedDiagnostics #PoweringPatientCare

Today is Rare Disease Day, a global movement aimed at raising awareness and understanding of rare diseases and their impact on individuals and families. With approximately 300 million people worldwide living with rare diseases, this day is a reminder of the unique challenges they face in diagnosis, treatment, and everyday life. MAC Clinical Research has worked on a number of clinical trials for rare diseases and conditions that affect fewer than 1 in 2,000 people such as Sickle Cell disease, Idiopathic Pulmonary Fibrosis (IPF), and Alpha-1 Antitrypsin deficiency. We should also take this opportunity to recognise the tireless efforts of carers, researchers, and healthcare professionals dedicated to supporting people living with rare diseases. With greater awareness and collaboration, we can work towards improving access to treatments, advancing research, and ultimately enhancing the quality of life for those affected by rare diseases. If you would like to speak to us about our experience in this area, or would like more information on how we can support your study, contact us here: https://lnkd.in/exxCw9_U #cro #clinicalresearch #RareDiseaseDay #RareDiseaseAwareness 

Today is Rare Disease Day. For many, it's a day that goes beyond awareness. It's a day to acknowledge the incredible strength and resilience of those living with a rare disease, and their families. Paul Janssen used to always remind everyone that ‘patients are waiting’, and we know that waiting can be incredibly difficult. Waiting for a diagnosis, waiting for treatment, waiting for answers. we are not standing still. We're actively working to change that. At Johnson & Johnson Innovative Medicine, we're chasing down breakthroughs in a variety of rare diseases such as PAH, AL amyloidosis, myasthenia gravis, rare inherited retinal diseases, rare maternal-foetal diseases, and rare blood disorders and cancers. Together, let's keep fighting for a future where no one has to wait for a chance at a healthier life. #RareDiseaseDay #MyCompany

Tomorrow is Leap Day, and on this rarest of days, I support Rare Disease Day. Did you know that 70% of genetic rare diseases start in childhood? As a parent of a child with Spinal Muscular Atrophy, a rare neuromuscular disease, I understand the importance of raising awareness about these conditions. Awareness leads to funding, to treatment, to lives lived to the fullest. Join me in supporting Rare Disease Day by visiting rarediseaseday.org to learn more about these conditions and how we can make a difference. For more information on Spinal Muscular Atrophy, visit curesma.org. Let's work together to bring attention to these often-overlooked diseases and support those affected by them. #RareDiseaseDay #SpinalMuscularAtrophy #RareDiseaseAwareness

At HRA Pharma Rare Diseases, our mission deepens. Committed to elevating standards in healthcare, we focus on rare endocrine diseases, particularly on Cushing's syndrome and adrenocortical carcinoma. With a global reach, we work on making our products available all around the world and actively raising awareness to improve outcomes. This year, we are all geared up to embrace the unique challenges posed by Cushing's syndrome and adrenocortical carcinoma. We believe that together, towards the future, we can accelerate the development of solutions, ensuring that no patient is left behind in the pursuit of better health. #RareDiseases #Cushingssyndrome #adrenocorticalcarcinoma #2024Outlook #HRAPharmaRareDiseases

Sickle Cell Disease is an inherited blood disorder characterized by the production of abnormal hemoglobin. This abnormality red blood cells to become rigid, sticky, and shaped like crescent moons or sickles, which can block blood flow and break apart easily leading to pain, infections, and other serious health complications. On June 19 every year, the global communities come together to observe the World Sickle Cell Day, a day dedicated to raising awareness about sickle cell disease (SCD) and supporting individuals and families affected by this genetic blood disorder. The Sickle Cell Disease Association of America (SCDAA) invites everyone to commemorate World Sickle Cell Day with the inspiring theme, “Hope Through Progress: Advancing Sickle Cell Care Globally.” This theme highlights the collective effort required to enhance the lives of individuals affected by sickle cell disease (SCD) through improvements in care, research, and global awareness. Join us in the fight against sickle cell disease! Together, we can bring hope through progress. #WorldSickleCellDay #HopeThroughProgress #SickleCellAwareness #AdvancingSCDCare #HealthForAll #GlobalHealth #YoloHealth

#Innovation is at the heart of what we do at the Institute for Regeneration and Repair. In our third session, we hear from our Innovation Competition finalists as they share their project proposals for tackling conditions such as liver disease (Jacky Tam), microbial keratitis (Leonie Fingerhut), neurodegenerative diseases (Rebecca Saleeb) and chronic wound healing (Yonlada Nawilaijaroen). #IRRSymposium24